Filtered By:
Condition: Hemorrhagic Stroke
Infectious Disease: COVID-19
This page shows you your search results in order of relevance. This is page number 12.
Order by Relevance | Date
Total 1354 results found since Jan 2013.
Post-stroke aphasia at the time of COVID-19 pandemic: a telerehabilitation perspective
We report on our remote speech therapy experience in post-stroke aphasia. The aim was to test the feasibility and utility of telerehabilitation to support future randomized controlled trials. Post-stroke aphasia is a common and disabling speech disorder, which significantly affects patients' and caregivers' health and quality of life. Due to COVID-19 pandemic, most of the conventional speech therapy approaches had to stop or "switch" into telerehabilitation procedures to ensure the safety of patients and operators but, concomitantly, the best rehabilitation level possible. Here, we planned a 5-month telespeech therapy prog...
Source: Journal of Integrative Neuroscience - February 15, 2022 Category: Neuroscience Authors: Laura Cassarino Franca Santoro Donatella Gelardi Simonetta Panerai Maurizio Papotto Mariangela Tripodi Filomena Irene Ilaria Cosentino Vincenzo Neri Raffaele Ferri Salvatore Ferlito Daniela Modica Francesco Fisicaro Manuela Pennisi Rita Bella Giuseppe Lan Source Type: research
Efficacy and safety of recanalization therapy for acute ischemic stroke with COVID-19: A systematic review and meta-analysis
ConclusionsCompared with COVID-19 negative AIS patients who received recanalization treatments, COVID-19 positive patients turned out to have poorer outcomes. Particular attention needs to be paid to the treatments for these COVID-19 patients to decrease mortality and morbidity. Long-term follow-up is necessary to evaluate the recanalization treatments for AIS patients with COVID-19.Systematic review registrationhttps://inplasy.com/inplasy-2022-4-0022/, identifier: INPLASY202240022.
Source: Frontiers in Neurology - August 30, 2022 Category: Neurology Source Type: research
Consider alternative causes before allocating acute ischaemic stroke to COVID-19
We read with interest the excellent article by Dmytriw et al reported on a retrospective, multicenter cohort study of patients with COVID-19 with acute ischaemic stroke (AIS) admitted to stroke units in the USA and Canada between March and August 2020.1 The primary endpoint was a modified Rankin Scale (mRS) of 5–6 and the secondary endpoints were an mRS<3, ordinal RS, symptomatic intracerebral haemorrhage and complications during hospitalisation.1 It has been established that there may be an association between COVID-19-associated AIS and severe outcome or death, and that the neutrophil to lymphocyte ratio predict...
Source: Journal of Neurology, Neurosurgery and Psychiatry - September 14, 2022 Category: Neurosurgery Authors: Finsterer, J. Tags: COVID-19 PostScript Source Type: research
The impact of COVID-19 pandemic on treatment delay and short-term neurological functional prognosis for acute ischemic stroke during the lockdown period
ConclusionThe COVID-19 pandemic has had remarkable impacts on the management of AIS. The pandemic might exacerbate certain time delays and play a significant role in early adverse outcomes in patients with AIS.
Source: Frontiers in Neurology - October 20, 2022 Category: Neurology Source Type: research
Antiphospholipid antibodies in patients with stroke during COVID-19: A role in the signaling pathway leading to platelet activation
ConclusionsThis study demonstrates the presence of aPLs in a subgroup of COVID-19 patients who presented AIS, suggesting a role in the mechanisms contributing to hypercoagulable state in these patients. Detecting these antibodies as a serological marker to check and monitor COVID-19 may contribute to improve the risk stratification of thromboembolic manifestations in these patients.
Source: Frontiers in Immunology - March 2, 2023 Category: Allergy & Immunology Source Type: research
Reversible Cerebral Vasoconstriction Syndrome and Dissection in the Setting of COVID-19 Infection
The current COVID-19 pandemic has recently brought to attention the myriad of neuro- logic sequelae associated with Coronavirus infection including the predilection for stroke, particularly in young patients. Reversible cerebral vasoconstriction syndrome (RCVS) is a well-described clinical syndrome leading to vasoconstriction in the intracra- nial vessels, and has been associated with convexity subarachnoid hemorrhage and oc- casionally cervical artery dissection. It is usually reported in the context of a trigger such as medications, recreational drugs, or the postpartum state; however, it has not been described in COVID-19 infection.
Source: Journal of Stroke and Cerebrovascular Diseases - June 4, 2020 Category: Neurology Authors: Katarina Dakay, Gurmeen Kaur, Edwin Gulko, Justin Santarelli, Christian Bowers, Stephan A Mayer, Chirag D Gandhi, Fawaz Al-Mufti Tags: Case Report Source Type: research
Concurrent Acute Ischemic Stroke and Non-aneurysmal Subarachnoid Hemorrhage in COVID-19.
PMID: 33148353 [PubMed - as supplied by publisher]
Source: The Canadian Journal of Neurological Sciences - November 5, 2020 Category: Neurology Authors: de Castillo LLC, Ignacio KHD, Separa KJNJ, Diestro JDB, Pasco PMD, P Franks MC Tags: Can J Neurol Sci Source Type: research
Risk of Hemorrhagic Stroke in Patients With Coronavirus Disease 2019 —Reply
In Reply We thank Dr Silverman and colleagues for their interest in our study and providing us the opportunity to expand on our results. Among the 1916 patients who visited the emergency department or were hospitalized with coronavirus disease 2019 (COVID-19) in our study, 8 patients (0.4% [95% CI, 0.2%-0.8%]) had hemorrhagic stroke, including 7 with intracerebral hemorrhage and 1 with subarachnoid hemorrhage. Among these 8 patients, 4 strokes were attributed to anticoagulant use.
Source: JAMA Neurology - March 8, 2021 Category: Neurology Source Type: research
COVID-19 in combination with hemorrhagic stroke doubles death risk
(University of Utah Health) COVID-19 and hemorrhagic stroke are a deadly combination, increasing the risk of death up to 2.4 times among patients who have this pairing compared to those who only had hemorrhagic strokes, according to a nationwide study led by University of Utah Health scientists. Patients who survived had longer hospital stays, more medical complications, and less favorable outcomes than those who did not have both conditions.
Source: EurekAlert! - Infectious and Emerging Diseases - April 14, 2021 Category: Infectious Diseases Source Type: news
Hemorrhagic Stroke + COVID-19 Doubles Risk for In-Hospital Mortality
FRIDAY, April 16, 2021 -- COVID-19 ups the risk for death with hemorrhagic stroke by more than twofold, according to a study published online April 14 in PLOS ONE.
Vijay M. Ravindra, M.D., from the Naval Medical Center San Diego, and colleagues...
Source: Drugs.com - Pharma News - April 16, 2021 Category: Pharmaceuticals Source Type: news
High incidence of stroke and mortality in pediatric critical care patients with COVID-19 in Peru
CONCLUSION: Cerebrovascular events associated with COVID-19 in pediatric patients, including infants, must be recognized as one of the more severe presentations of this infection in pediatric patients.IMPACT: Pediatric patients with COVID-19 can present with hemorrhagic and ischemic strokes on presentation. Neurological presentation in pediatric patients with COVID-19 has high mortality. Mortality of pediatric patients with COVID-19 is associated with comorbidities. Pediatric presentation and outcomes of COVID-19 in different regions can be novel to previously described.PMID:33941862 | DOI:10.1038/s41390-021-01547-x
Source: Pediatric Research - May 4, 2021 Category: Pediatrics Authors: Alvaro Coronado Munoz Jaime Tasayco Willy Morales Luis Moreno David Zorrilla Angie Stapleton Patricia Pajuelo Giuliana Reyes Matilde Estupi ñan Ricardo Seminario Manuel Ortiz Jes ús Domínguez Source Type: research
Hemorrhagic stroke associated to COVID-19 infection in Mexico General Hospital
CONCLUSIONES: la HC se asocia a la infección por SARS-CoV-2 con mal pronóstico cuando se presenta. Los equipos de neurocirugía deben estar preparados para el tratamiento oportuno de estos pacientes.INTRODUCTION: In the current COVID-19 pandemic, there is a growing body of evidence that has identified the neurotropism of the SARS-CoV-2 virus and its neurological complications, including cerebrovascular disease, focusing mainly in ischemic and scarcely about hemorrhagic stroke (HS).OBJECTIVE: The objective of the study was to describe clinical, radiological, laboratory tests, and prognostic characteristics of patients wit...
Source: Cirugia y Cirujanos - August 5, 2021 Category: Surgery Authors: Gustavo Parra-Romero Ariatne Mar- Álvarez Jos é L Navarro-Olvera Aldo F Hern ández-Valencia Gustavo Aguado-Carrillo Jos é D Carrillo-Ruiz Source Type: research
